-
-
-
-
-
-
-
Cue Biopharma, Inc. (CUE) Tops Q2 EPS by 5c
-
-
-
-
-
-
-
Cue Biopharma Reports Third Quarter 2024 Financial Results and Recent Business Highlights
-
-
-
-
-
-
-
Cue Biopharma, Inc. (CUE) Tops Q2 EPS by 2c
-
-
-
-
-
-
-
Cue Biopharma (CUE) PT Lowered to $10 at Oppenheimer
-
-
-
-
-
-
-
Cue Biopharma Reports First Quarter 2021 Results, Recent Updates of CUE-101 Phase 1 Dose Escalation Study, Platform Progress and Business Highlights
-
-
-
-
-
-
-
Cue Biopharma Reports Second Quarter 2020 Results and CUE-101 Phase 1 Dose Escalation Trial Updates
-
-
-
-
-
-
-
Cue Biopharma Reports Third Quarter 2019 Financial Results and Recent Business Highlights
1,199,636 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

